4//SEC Filing
Cohen Joshua B 4
Accession 0000950170-24-109397
CIK 0001658551other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 5:56 PM ET
Size
6.5 KB
Accession
0000950170-24-109397
Insider Transaction Report
Form 4
Cohen Joshua B
DirectorCo-Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-23$1.57/sh+1,857$2,915→ 3,239,158 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-23−1,857→ 0 totalExercise: $1.57Exp: 2025-02-26→ Common Stock (1,857 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001898644
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 5:56 PM ET
- Size
- 6.5 KB